"专家访谈"标签列表

[HFAL2011]干细胞治疗终末期肝病的现状与发展2011-04-01

[APASL2011]HCC Risk Prediction Scoring System Needs Further Validation2011-02-23

[APASL2011]HCC的风险预测评分系统仍需进一步验证——香港大学袁孟峰教授访谈2011-02-23

[APASL2011]6个月的HCC筛查间隔符合成本效益——意大利米兰大学Massimo Colombo教授访谈2011-02-23

[APASL2011]The Six Month Interval of HCC is Cost Effective-Interview with Prof. Massimo Colombo2011-02-23

[APASL2011]Therapy Strategy for Patients with Hepatitis B Resistance-Interview with Prof. Lampertico2011-02-23

[APASL2011]乙肝耐药挽救治疗策略——意大利米兰Pietro Lampertico教授访谈2011-02-23

[APASL2011]HCC Risk Factors Associated with Patients with Chronic Hepatitis B-Interview with Prof.Chan Pei Jer2011-02-23

[APASL2011]加强基础与临床的协作、扩大与其他协会的交流——大会主席Teerha Piratvisuth教授访谈2011-02-21

[APASL2011]Interview with Prof. Teerha Piratvisuth2011-02-21

[APASL2011]Issues Associated with Anti-hepatitis B Viral Drug—Interview with Prof. Emmet B. Keeffe2011-02-21

[APASL2011]乙型肝炎抗病毒药物临床应用相关问题——美国斯坦福大学Emmet B. Keeffe教授2011-02-21

[APASL2011]Hepatitis B reactivation mechanism needs More study-Interview with Prof. Antonio Berloletti2011-02-21

[APASL2011]乙型肝炎再激活的机制需要深入研究——新加坡临床科学研究院Antonio Berloletti教授访谈2011-02-21

[APASL2011]HCC的新型诊断方法——日本东京大学M.Omata教授访谈2011-02-19

[APASL2011]The new diagnostic method of HCC——Interview with Professor M Omata from Tokyo university2011-02-19

[APASL2011]Making Optimal Therapy Profile for HCC by Assessing a Patient’s Baseline Life Expectancy-Interview with Prof. Jordi Bruix2011-02-19

[APASL2011]通过评估HCC患者的基线生命预期制定最佳治疗策略——西班牙巴塞罗那大学Jordi Bruix教授访谈2011-02-19

[APASL2011]Hepatitis C Clinical Trial Results Mixed Picture——Interview with Professor JM.Pawlotsky2011-02-19

[APASL2011]A Successful Experience for Reducing the Rate of HCC from Japan_ Interview with Ryosuke Tateishi2011-02-19